This article was written by

Analyst’s Disclosure: I/we have a beneficial long position in the shares of KO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SGX Group reported strong trading in May, with securities turnover up 70%, derivatives volume up 20%, and institutional interest in small stocks driving record highs in the Singapore market.

---

SGX Group (Singapore Exchange) reported robust trading activity in May amid sustained investor participation, as Singapore’s stock market became Southeast Asia’s largest by market capitalisation and demand for trusted risk-management tools expanded across equities, FX and commodities.

Securities market turnover value rose 70% year-on-year (y-o-y) to S$45.8 billion, with securities daily average value (SDAV) climbing 79% to S$2.4 billion – the highest since October 2007. Derivatives traded volume increased 20% y-o-y to 30.5 million contracts, while daily average volume (DAV) gained 27% to 1.6 million contracts, the third-largest on record.

Key highlights:

• Strong momentum in small- and mid-cap stocks: The benchmark Straits Times Index advanced 3.5% month-on-month (m-o-m) in May, reaching an all-time high of 5,072 on 19 May amid banking- and technology-led gains. STI exchange-traded funds (ETF) marked a 15th consecutive month of net inflows with S$129 million in May and S$687 million year-to-date (YTD). Momentum in small- and mid-cap stocks excluding REITs continued to accelerate, as SDAV rose 24% m-o-m and more than four times y-o-y. Institutional investors remained net buyers of small- and mid-caps for a fifth consecutive month, bringing total inflows over the past 12 months to over S$800 million.
• Investor participation strengthens across securities: SDAV increased across all investor segments, led by institutional investors with incremental S$184 million m-o-m growth. Retail SDAV climbed 11% m-o-m, surpassing the February peak and setting a 13-year high. Cumulative net inflows by retail investors exceeded S$1.5 billion over the first five months of this year, reflecting sustained interest in Singapore equities.
• Capital-raising activity gathers pace: SGX Stock Exchange on 22 May welcomed JustCo Holdings Limited, a leading flexible-workspace operator with an established Asia-Pacific footprint, to its Mainboard. Three Catalist companies – Lum Chang Creations Limited, CNMC Goldmine Holdings Limited, and Koh Brothers Eco Engineering Limited – announced transfers to the Mainboard. Secondary placements by non-REIT issuers including Hong Leong Asia Ltd. and Aspial Lifestyle Limited raised a combined S$316 million.
• Risk-managing India equities: Global investors turned to SGX Derivatives for their risk-transfer instrument of choice for India equities. DAV in GIFT Nifty 50 Index Futures and Options gained 6% m-o-m in May to 112,894 contracts, underpinned by broad-based and active participation across customer segments. Open interest (OI) was up 12% m-o-m at 290,377 contracts (US$13.7 billion notional), a record high.
• Round-the-clock activity in FX futures: Market participants actively managed risk through FX futures as signs of a resilient U.S. economy placed sustained pressure on Asian currencies. DAV across all listed FX futures rose 29.6% y-o-y in May to 505,864 lots (US$29 billion notional), with average OI up 18.9% y-o-y at 544,651 lots (US$31.5 billion notional). The SGX KRW/USD FX Futures (Mini) contract saw peak activity in the European afternoon/U.S. morning, while month-end OI in SGX TWD/USD FX Futures climbed 37% m-o-m.
• Broad-based growth across commodities: DAV across SGX Commodities rose 4.7% y-o-y in May, supported by increased trading in bellwether iron ore contracts, forward freight agreements (FFA) and SGX SICOM rubber derivatives. Average OI for the YTD through May gained 20.6% y-o-y, reflecting sustained hedging demand. Container FFA activity was robust, with volumes reaching a new high of 2,568 contracts.

The full market statistics report can be found here.

Source : SGX Group records strong May performance with new volume highs across asset classes

Other People are Reading

Shares of Kalyan Jewellers India fell 7.3% to Rs 352.60 on the BSE during Tuesday’s trading session, despite the company reporting a strong Q1 business update. The company reported around 38% year-on-year (YoY) consolidated revenue growth, driven by strong performance across its domestic and international operations.

Kalyan Jewellers said consolidated revenue grew around 38% YoY for the June-ended quarter, supported by healthy consumer demand.

Revenue from its India business also rose over 38%, with same-store sales growth of around 28%, despite the quarter coinciding with the 28-day Adhik Maas period, a once-in-three-year phase that typically slows wedding-related jewellery purchases in several parts of the country.

The company also reported encouraging progress from its ‘Shine with India’ gold recirculation campaign, launched in May to boost the use of recycled gold and reduce dependence on imports. Recycled gold accounted for over 46% of revenue during the quarter, with the contribution exceeding 55% in June alone.

Kalyan Jewellers’s international business delivered around 35% YoY revenue growth, while its Middle East operations grew nearly 30%, supported by strong same-store sales despite softer footfall in April amid geopolitical tensions. Overseas markets contributed approximately 14% of consolidated revenue during the quarter.

Meanwhile, Candere, Kalyan’s digital-first jewellery platform, continued its rapid expansion, posting 112% YoY revenue growth compared with the same period last year.
The retailer also strengthened its physical footprint by opening 12 Kalyan Jewellers showrooms and five Candere stores across India during the quarter.Despite the upbeat operational performance, investors appeared to book profits, sending the stock sharply lower. The decline indicates investors may have booked profits despite the strong business update, with the market likely awaiting the company’s detailed quarterly earnings, including profitability and margin trends.

Share Price Trend and Technical Indicators

Kalyan Jewellers shares have declined around 35% over the past year. The company currently commands a market capitalisation of Rs 39,373 crore.

On the technical front, the stock’s 14-day Relative Strength Index (RSI) stands at 53.9. An RSI reading below 30 is generally considered oversold, while a reading above 70 indicates overbought conditions. In terms of moving averages, the stock remains under pressure, trading below all eight of its key Simple Moving Averages (SMAs), indicating a bearish technical trend.

(Disclaimer: Recommendations, suggestions, views, and opinions expressed by the experts are their own and do not represent the views of The Economic Times)

WASHINGTON — Sen. Mitch McConnell has spent more than three weeks in the hospital, and his office still has not disclosed what led to his admission, his current condition, or when he might be able to return to the Senate floor.

McConnell, 84, a Kentucky Republican who has served in the Senate since 1985 and led Senate Republicans from 2007 until 2025, has not cast a vote since June 11. His extended absence comes at a delicate moment for Senate Republicans, who are navigating a narrow majority in the chamber, and it has already contributed to delays in the Appropriations Committee’s work on spending legislation.

McConnell was admitted to the hospital on the morning of June 14, according to a statement from his office at the time, which said only that he was “receiving excellent care.” EMS dispatch audio from that morning indicates emergency medical personnel were sent to McConnell’s home to respond to an unconscious person in cardiac arrest. According to the recording, a call went out at 8:36 a.m. reporting an unconscious person at McConnell’s address, prompting the dispatch of an ambulance with an advanced life support crew. Within six minutes, a medic radioed that CPR was in progress, and by 8:43 a.m., a dispatcher had relayed the emergency as a cardiac arrest. McConnell is not named anywhere in the recording, though the address matches his residence.

The following day, Senate Majority Leader John Thune of South Dakota and Senate Majority Whip John Barrasso of Wyoming, the chamber’s top two Republicans, told reporters they had spoken with McConnell directly.

In the weeks since, McConnell’s office has offered only sparse updates on his condition. On June 22, eight days after his hospitalization began, his office said he would not be voting that week “as he continues his recovery.” Thune, speaking to reporters the same day, said he had spoken with McConnell “toward the end of last week” and that McConnell “sounded good and was anxious to get back.”

A subsequent statement from McConnell’s office on July 2 offered little additional detail but confirmed he remained hospitalized. “The Senator continues to improve, and is working closely with his staff on Kentucky and Senate matters while the Senate is out of session,” the office said. McConnell’s office has not provided further updates since that statement and did not respond to a request for comment on Monday.

McConnell’s continued absence carries practical consequences for Senate Republicans. Any extended absence would temporarily shrink the party’s working majority to 52-47 in the chamber, complicating efforts to advance legislation that requires a simple majority. His absence has also added further strain to the Senate Appropriations Committee, which was already behind schedule due to disagreements over defense funding and had not advanced any spending bills for the 2027 fiscal year as of early July. Without McConnell present, the committee is evenly split between Republicans and Democrats, meaning any vote that falls along party lines would fail to advance. According to a Republican aide who spoke on the condition of anonymity, the committee had already postponed plans to mark up spending bills during the week of June 22, in part because of McConnell’s absence.

McConnell announced earlier this year that he would not seek reelection and is set to retire from the Senate in January, at the conclusion of his current term, bringing an end to a legislative career that has spanned four decades.

McConnell’s health has drawn public attention on multiple occasions in recent years. He contracted polio as a child, a bout of illness that has long affected his mobility and made climbing stairs difficult. In March 2023, he was hospitalized after a fall at a Washington hotel and remained away from the Senate floor for several weeks. Later that year, he experienced two widely covered episodes in which he abruptly stopped speaking during televised news conferences and had to be assisted by colleagues before regaining his composure. He was injured again in December 2024 after tripping outside a Senate Republican lunch, and earlier this year he spent more than a week in the hospital after his office attributed the stay to flu-like symptoms.

The current hospitalization, now stretching beyond three weeks, represents McConnell’s longest known absence from the Senate due to health concerns during his time in office. His office’s limited public disclosures have left colleagues, constituents and observers largely reliant on secondhand accounts from Senate leadership regarding his condition and prognosis.

As of this report, no additional details have emerged regarding the nature of McConnell’s underlying medical condition, the treatment he has received during his hospitalization, or a specific timeline for his return to the Senate. His office has continued to describe his condition only in general terms, emphasizing ongoing improvement without elaborating on the circumstances that led to his initial hospitalization on June 14.

With the Senate’s spending process already delayed and McConnell’s continued absence further narrowing the chamber’s Republican majority, his colleagues in Senate leadership are likely to continue facing questions about the practical impact of his hospitalization on the chamber’s legislative agenda in the weeks ahead, even as his office maintains a limited public accounting of his health status heading into the final months of his Senate career.

This is the forum for daily political discussion on Seeking Alpha. A new version is published every market day.

Please don’t leave political comments on other articles or posts on the site.

The comments below are not regulated with the same rigor as the rest of the site, and this is an ‘enter at your own risk’ area as discussion can get very heated. If you can’t stand the heat… you know what they say…

More on Today’s Markets:

Moderation Guidelines:

We remove comments under the following categories:

• Personal attacks on another user account
• Anti-Vaxxer or covid related misinformation
• Stereotyping, prejudiced or racist language about individuals or the topic under discussion.
• Inciting violence messages, encouraging hate groups and political violence.

Regardless of which side of the political divide you find yourself, please be courteous and don’t direct abuse at other users.

For any issue with regards to comments please email us at : moderation@seekingalpha.com.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.